Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


14 Ann Intern Med
3 Biochem Biophys Res Commun
1 Biochemistry
2 Biochemistry (Mosc)
1 BMC Pediatr
2 Drugs
1 Epidemiol Infect
4 Eur J Epidemiol
2 J Exp Med
1 J Gen Virol
1 J Infect
6 J Infect Dis
3 J Virol
5 Lancet
9 MMWR Morb Mortal Wkly Rep
15 N Engl J Med
1 PLoS Biol
3 PLoS Comput Biol
44 PLoS One
6 Proc Natl Acad Sci U S A
1 Vaccine
7 Virology
2 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. NEWTON SL, Yeh JS
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:582-583.

  2. CHOU R, Dana T, Jungbauer R, Weeks C, et al
    Update Alert 5: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.
    Ann Intern Med. 2021 Mar 9. doi: 10.7326/L21-0116.

  3. LOEB M
    Joint testing of IgM and IgG has high value for ruling in SARS-CoV-2 infection.
    Ann Intern Med. 2021 Apr 6. doi: 10.7326/ACPJ202104200.
    PubMed         Abstract available

    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583.

  5. CHOW EJ, O'Halloran A, Rolfes MA, Reed C, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583-584.

  6. COOPER LA, Stoney CM
    Messages to Increase COVID-19 Knowledge in Communities of Color: What Matters Most?
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-8057.

  7. HARADA KH, Harada Sassa M
    Cloth Masks May Prevent Transmission of COVID-19.
    Ann Intern Med. 2021;174:579.

    Cloth Masks May Prevent Transmission of COVID-19.
    Ann Intern Med. 2021;174:579.

    Cloth Masks May Prevent Transmission of COVID-19.
    Ann Intern Med. 2021;174:579-580.

  10. CLASE CM, Fu EL, Jardine M, Mann JFE, et al
    Cloth Masks May Prevent Transmission of COVID-19.
    Ann Intern Med. 2021;174:580.

  11. HILL C, Thuret JY
    The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs.
    Ann Intern Med. 2021;174:582.

  12. DEL AMO J, Polo R, Moreno S, Diaz A, et al
    Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
    Ann Intern Med. 2021;174:581-582.

  13. TITANJI B, Hernandez-Romieu AC, Adelman MW
    Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
    Ann Intern Med. 2021;174:580-581.

    U.S. COVID-19 Vaccination Challenges Go Beyond Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8280.

    Biochem Biophys Res Commun

    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;534:374-380.
    PubMed         Abstract available

  16. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    PubMed         Abstract available

  17. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    PubMed         Abstract available


  18. BRAVO MF, Lema MA, Marianski M, Braunschweig AB, et al
    Flexible Synthetic Carbohydrate Receptors as Inhibitors of Viral Attachment.
    Biochemistry. 2021;60:999-1018.
    PubMed         Abstract available

    Biochemistry (Mosc)

  19. RYZHIKOV AB, Onkhonova GS, Imatdinov IR, Gavrilova EV, et al
    Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.
    Biochemistry (Mosc). 2021;86:243-247.
    PubMed         Abstract available

  20. LETAROV AV, Babenko VV, Kulikov EE
    Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
    Biochemistry (Mosc). 2021;86:257-261.
    PubMed         Abstract available

    BMC Pediatr

  21. LU W, Yang L, Li X, Sun M, et al
    Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.
    BMC Pediatr. 2021;21:181.
    PubMed         Abstract available


  22. KAMPMANN B, Jack SM
    Covid-19 vaccines save lives.
    BMJ. 2021;373:n886.

  23. PUHAN MA, Chiolero A, Fehr J, Cullati S, et al
    Overcoming spectrum bias for accurate SARS-CoV-2 seroprevalence estimates.
    BMJ. 2021;373:n917.

  24. AGIUS RM, Hughes LT, Kendrick D, Robertson JFR, et al
    Assessing risk for healthcare workers during the pandemic: don't forget workplace safety committees or aerosol generating procedures.
    BMJ. 2021;373:n950.


  25. HEO YA
    Voclosporin: First Approval.
    Drugs. 2021;81:605-610.
    PubMed         Abstract available

  26. HUM C, Loiselle J, Ahmed N, Shaw TA, et al
    MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
    Drugs. 2021;81:517-531.
    PubMed         Abstract available

    Epidemiol Infect

  27. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    PubMed         Abstract available

    Eur J Epidemiol

  28. FAN X, Yin C, Wang J, Yang M, et al
    Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Eur J Epidemiol. 2021;36:311-318.
    PubMed         Abstract available

  29. ELLIOTT J, Bodinier B, Whitaker M, Delpierre C, et al
    COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
    Eur J Epidemiol. 2021;36:299-309.
    PubMed         Abstract available

  30. TERZIKHAN N, Hofman A, Goudsmit J, Ikram MA, et al
    External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
    Eur J Epidemiol. 2021;36:319-324.
    PubMed         Abstract available

  31. BERGMAN J, Ballin M, Nordstrom A, Nordstrom P, et al
    Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Eur J Epidemiol. 2021;36:287-298.
    PubMed         Abstract available

    J Exp Med

  32. LANZ C, Schotsaert M, Magnus C, Karakus U, et al
    IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  33. MERAD M, Vabret N
    Highlights from a year in a pandemic.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Gen Virol

  34. HENSS L, Auste A, Schurmann C, Schmidt C, et al
    The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Infect

  35. FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
    Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
    J Infect. 2021;82:282-327.

    J Infect Dis

  36. RATHE JA, Hemann EA, Eggenberger J, Li Z, et al
    SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
    J Infect Dis. 2021;223:1120-1131.
    PubMed         Abstract available

  37. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    PubMed         Abstract available

  38. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    PubMed         Abstract available

  39. TJAN LH, Furukawa K, Nagano T, Kiriu T, et al
    Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1145-1149.
    PubMed         Abstract available

  40. EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
    Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
    J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
    PubMed         Abstract available

  41. MCCARTNEY MM, Linderholm AL, Yamaguchi MS, Falcon AK, et al
    Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions.
    J Infect Dis. 2021 Apr 15. pii: 6226913. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  42. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    PubMed         Abstract available

  43. CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
    Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
    J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
    PubMed         Abstract available

  44. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    PubMed         Abstract available


  45. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.

  46. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.

  47. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.

  48. TENFORDE MW, Fisher KA, Patel MM
    Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures.
    JAMA. 2021 Feb 22. pii: 2776937. doi: 10.1001/jama.2021.1995.

  49. RASCHKE RA, Agarwal S, Rangan P, Heise CW, et al
    Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation.
    JAMA. 2021 Feb 17. pii: 2776737. doi: 10.1001/jama.2021.1545.

  50. ZHANG W, Davis BD, Chen SS, Sincuir Martinez JM, et al
    Emergence of a Novel SARS-CoV-2 Variant in Southern California.
    JAMA. 2021 Feb 11. pii: 2776543. doi: 10.1001/jama.2021.1612.

  51. BEARD JH, Jacoby SF, Maher Z, Dong B, et al
    Changes in Shooting Incidence in Philadelphia, Pennsylvania, Between March and November 2020.
    JAMA. 2021;325:1327-1328.

  52. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.

  53. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.

  54. FONTANAROSA PB, Bauchner H, Golub R
    To JAMA Authors, Reviewers, and Especially Physician Readers-A Profound Thank You.
    JAMA. 2021;325:1263-1265.

    Sitting in the River.
    JAMA. 2021;325:1255-1256.

  56. ABBASI J
    How the US Failed to Prioritize SARS-CoV-2 Variant Surveillance.
    JAMA. 2021 Mar 24. pii: 2777988. doi: 10.1001/jama.2021.3368.

  57. LEFRERE B, Recoing A, Delacour H
    COVID-19 Postage Stamps-Messages in a Message.
    JAMA. 2021 Mar 22. pii: 2777922. doi: 10.1001/jama.2021.2139.

  58. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.

  59. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.

  60. LOPEZ-MEDINA E, Lopez P, Hurtado IC, Davalos DM, et al
    Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Mar 4. pii: 2777389. doi: 10.1001/jama.2021.3071.
    PubMed         Abstract available


  61. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    PubMed         Abstract available

  62. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.

  63. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.

  64. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    PubMed         Abstract available

  65. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.

    MMWR Morb Mortal Wkly Rep

  66. SMITH AR, DeVies J, Caruso E, Radhakrishnan L, et al
    Emergency Department Visits for COVID-19 by Race and Ethnicity - 13 States, October-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:566-569.
    PubMed         Abstract available

  67. LEWIS NM, Hershow RB, Chu VT, Wu K, et al
    Factors Associated with Participation in Elementary School-Based SARS-CoV-2 Testing - Salt Lake County, Utah, December 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:557-559.
    PubMed         Abstract available

  68. ROSSEN LM, Branum AM, Ahmad FB, Sutton PD, et al
    Notes from the Field: Update on Excess Deaths Associated with the COVID-19 Pandemic - United States, January 26, 2020-February 27, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:570-571.

  69. COVID-19 Stats: COVID-19* and Influenza(dagger) Discharge Diagnoses as a Percentage of Emergency Department (ED) Visits,( section sign) by Year - United States, June 2018-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:573.

  70. ROMANO SD, Blackstock AJ, Taylor EV, El Burai Felix S, et al
    Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region - United States, March-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:560-565.
    PubMed         Abstract available

  71. ADJEMIAN J, Hartnett KP, Kite-Powell A, DeVies J, et al
    Update: COVID-19 Pandemic-Associated Changes in Emergency Department Visits - United States, December 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:552-556.
    PubMed         Abstract available

  72. DIETRICH WL, Bennett JS, Jones BW, Hosni MH, et al
    Laboratory Modeling of SARS-CoV-2 Exposure Reduction Through Physically Distanced Seating in Aircraft Cabins Using Bacteriophage Aerosol - November 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:595-599.
    PubMed         Abstract available

  73. OHLSEN EC, Porter KA, Mooring E, Cutchins C, et al
    Airport Traveler Testing Program for SARS-CoV-2 - Alaska, June-November 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:583-588.
    PubMed         Abstract available

  74. DUNNE EM, Morgan E, Wells-Moore B, Pierson S, et al
    COVID-19 Outbreaks in Correctional Facilities with Work-Release Programs - Idaho, July-November 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:589-594.
    PubMed         Abstract available

    N Engl J Med

  75. DAGAN N, Barda N, Kepten E, Miron O, et al
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
    PubMed         Abstract available

  76. ABSALON J, Koury K, Gruber WC
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2021;384.

  77. WANG X
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.

    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.

  79. SKOWRONSKI DM, De Serres G
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.

    Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.

  81. LUNDH A
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.

  82. SALAMA C, Mohan SV
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.

  83. STONE JH
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.

  84. KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
    Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.

  85. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    N Engl J Med. 2021;384:e65.

  86. GAESTEL M, Nebreda AR, Yaffe MB
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.

  87. SUPADY A, Bode C, Duerschmied D
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.

  88. MUDD PA, Crawford JC, Thomas PG
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.

    Cytokine Storm. Reply.
    N Engl J Med. 2021;384:e59.

    PLoS Biol

  90. FRASER N, Brierley L, Dey G, Polka JK, et al
    The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
    PLoS Biol. 2021;19:e3000959.
    PubMed         Abstract available

    PLoS Comput Biol

  91. NANDA P, Ghosh A
    Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.
    PLoS Comput Biol. 2021;17:e1008860.
    PubMed         Abstract available

  92. WATSON GL, Xiong D, Zhang L, Zoller JA, et al
    Pandemic velocity: Forecasting COVID-19 in the US with a machine learning & Bayesian time series compartmental model.
    PLoS Comput Biol. 2021;17:e1008837.
    PubMed         Abstract available

  93. TORNERI A, Libin P, Scalia Tomba G, Faes C, et al
    On realized serial and generation intervals given control measures: The COVID-19 pandemic case.
    PLoS Comput Biol. 2021;17:e1008892.
    PubMed         Abstract available

    PLoS One

  94. FLORES-SILVA FD, Garcia-Grimshaw M, Valdes-Ferrer SI, Vigueras-Hernandez AP, et al
    Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City.
    PLoS One. 2021;16:e0247433.
    PubMed         Abstract available

  95. MELLHAMMAR L, Thelaus L, Elen S, Fisher J, et al
    Heparin binding protein in severe COVID-19-A prospective observational cohort study.
    PLoS One. 2021;16:e0249570.
    PubMed         Abstract available

  96. GADARIAN SK, Goodman SW, Pepinsky TB
    Partisanship, health behavior, and policy attitudes in the early stages of the COVID-19 pandemic.
    PLoS One. 2021;16:e0249596.
    PubMed         Abstract available

  97. MAHMUD R, Rassel MA, Monayem FB, Sayeed SKJB, et al
    Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh.
    PLoS One. 2021;16:e0249252.
    PubMed         Abstract available

  98. SWEENEY N, Merrick B, Pedro Galao R, Pickering S, et al
    Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.
    PLoS One. 2021;16:e0249791.
    PubMed         Abstract available

  99. LOPEZ-CASTRO T, Brandt L, Anthonipillai NJ, Espinosa A, et al
    Experiences, impacts and mental health functioning during a COVID-19 outbreak and lockdown: Data from a diverse New York City sample of college students.
    PLoS One. 2021;16:e0249768.
    PubMed         Abstract available

  100. MACIAS J, Gonzalez-Moreno P, Sanchez-Garcia E, Morillo-Verdugo R, et al
    Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
    PLoS One. 2021;16:e0249036.
    PubMed         Abstract available

  101. HE L, Zhou W, He M, Nie X, et al
    Openness and COVID-19 induced xenophobia: The roles of trade and migration in sustainable development.
    PLoS One. 2021;16:e0249579.
    PubMed         Abstract available

  102. MAHMUD R, Rahman MM, Rassel MA, Monayem FB, et al
    Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.
    PLoS One. 2021;16:e0249644.
    PubMed         Abstract available

  103. NOURINEJAD M, Berman O, Larson RC
    Placing sensors in sewer networks: A system to pinpoint new cases of coronavirus.
    PLoS One. 2021;16:e0248893.
    PubMed         Abstract available

  104. KINDGEN-MILLES D, Brandenburger T, Braun JFW, Cleff C, et al
    Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    PLoS One. 2021;16:e0248813.
    PubMed         Abstract available

  105. DEANGELIS HE, Grillet AM, Nemer MB, Wasiolek MA, et al
    Gamma radiation sterilization of N95 respirators leads to decreased respirator performance.
    PLoS One. 2021;16:e0248859.
    PubMed         Abstract available

  106. ISLAM MA, Kundu S, Alam SS, Hossan T, et al
    Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients.
    PLoS One. 2021;16:e0249788.
    PubMed         Abstract available

  107. YAMAL JM, Parker SA, Jacob AP, Rajan SS, et al
    Successful conduct of an acute stroke clinical trial during COVID.
    PLoS One. 2021;16:e0243603.
    PubMed         Abstract available

  108. MALMGREN J, Guo B, Kaplan HG
    Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020.
    PLoS One. 2021;16:e0243042.
    PubMed         Abstract available

  109. JAMES A, Plank MJ, Hendy S, Binny RN, et al
    Model-free estimation of COVID-19 transmission dynamics from a complete outbreak.
    PLoS One. 2021;16:e0238800.
    PubMed         Abstract available

  110. DIXON BE, Wools-Kaloustian KK, Fadel WF, Duszynski TJ, et al
    Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    PLoS One. 2021;16:e0241875.
    PubMed         Abstract available

  111. FRASCA D, Reidy L, Cray C, Diaz A, et al
    Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
    PLoS One. 2021;16:e0245424.
    PubMed         Abstract available

  112. EDWARDS B, Biddle N, Gray M, Sollis K, et al
    COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    PLoS One. 2021;16:e0248892.
    PubMed         Abstract available

  113. NEELON B, Mutiso F, Mueller NT, Pearce JL, et al
    Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States.
    PLoS One. 2021;16:e0248702.
    PubMed         Abstract available

  114. BRADFIELD Z, Wynter K, Hauck Y, Vasilevski V, et al
    Experiences of receiving and providing maternity care during the COVID-19 pandemic in Australia: A five-cohort cross-sectional comparison.
    PLoS One. 2021;16:e0248488.
    PubMed         Abstract available

  115. ARAGON-BENEDI C, Oliver-Fornies P, Galluccio F, Yamak Altinpulluk E, et al
    Is the heart rate variability monitoring using the analgesia nociception index a predictor of illness severity and mortality in critically ill patients with COVID-19? A pilot study.
    PLoS One. 2021;16:e0249128.
    PubMed         Abstract available

  116. NIQUE AM, Coronado-Marquina F, Mendez Rico JA, Garcia Mendoza MP, et al
    A faster and less costly alternative for RNA extraction of SARS-CoV-2 using proteinase k treatment followed by thermal shock.
    PLoS One. 2021;16:e0248885.
    PubMed         Abstract available

  117. SIKAKULYA FK, Ssebuufu R, Mambo SB, Pius T, et al
    Use of face masks to limit the spread of the COVID-19 among western Ugandans: Knowledge, attitude and practices.
    PLoS One. 2021;16:e0248706.
    PubMed         Abstract available

  118. BETTI M, Bertolotti M, Ferrante D, Roveta A, et al
    Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged
    PLoS One. 2021;16:e0248829.
    PubMed         Abstract available

  119. SICHONE J, Sinkala M, Munsaka S, Kikonko M, et al
    Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study.
    PLoS One. 2021;16:e0249479.
    PubMed         Abstract available

  120. SHIMELS T, Asrat Kassu R, Bogale G, Bekele M, et al
    Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic.
    PLoS One. 2021;16:e0249222.
    PubMed         Abstract available

  121. HIKI M, Tabe Y, Ai T, Matsue Y, et al
    Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    PLoS One. 2021;16:e0249449.
    PubMed         Abstract available

  122. MEHTA M, Purpura LJ, McConville TH, Neidell MJ, et al
    What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak.
    PLoS One. 2021;16:e0249349.
    PubMed         Abstract available

  123. GALIDO A, Ecleo JJ, Husnayain A, Chia-Yu Su E, et al
    Exploring online search behavior for COVID-19 preventive measures: The Philippine case.
    PLoS One. 2021;16:e0249810.
    PubMed         Abstract available

  124. AGUILAR-ORDONEZ I, Perez-Villatoro F, Garcia-Ortiz H, Barajas-Olmos F, et al
    Whole genome variation in 27 Mexican indigenous populations, demographic and biomedical insights.
    PLoS One. 2021;16:e0249773.
    PubMed         Abstract available

  125. MANENTI L, Maggiore U, Fiaccadori E, Meschi T, et al
    Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
    PLoS One. 2021;16:e0248276.
    PubMed         Abstract available

  126. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed         Abstract available

  127. Expression of Concern: Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones.
    PLoS One. 2021;16:e0250485.

  128. OWUSU M, Sylverken AA, El-Duah P, Ayisi-Boateng NK, et al
    Low risk of SARS-CoV-2 in blood transfusion.
    PLoS One. 2021;16:e0249069.
    PubMed         Abstract available

  129. SRIRAMAN K, Shaikh A, Parikh S, Udupa S, et al
    Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: Implications in understanding SARS-CoV2 transmission.
    PLoS One. 2021;16:e0249525.
    PubMed         Abstract available

  130. RASMUSSEN S, Petersen MS, Hoiby N
    SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future.
    PLoS One. 2021;16:e0249733.
    PubMed         Abstract available

  131. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    PubMed         Abstract available

  132. BROWNING R, Sulem D, Mengersen K, Rivoirard V, et al
    Simple discrete-time self-exciting models can describe complex dynamic processes: A case study of COVID-19.
    PLoS One. 2021;16:e0250015.
    PubMed         Abstract available

  133. YEO SC, Lai CKY, Tan J, Gooley JJ, et al
    A targeted e-learning approach for keeping universities open during the COVID-19 pandemic while reducing student physical interactions.
    PLoS One. 2021;16:e0249839.
    PubMed         Abstract available

  134. BORN B, Dietrich AM, Muller GJ
    The lockdown effect: A counterfactual for Sweden.
    PLoS One. 2021;16:e0249732.
    PubMed         Abstract available

  135. KWEON OJ, Lim YK, Kim HR, Choi Y, et al
    Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients.
    PLoS One. 2021;16:e0249972.
    PubMed         Abstract available

  136. ARSLANCA T, Fidan C, Daggez M, Dursun P, et al
    Knowledge, preventive behaviors and risk perception of the COVID-19 pandemic: A cross-sectional study in Turkish health care workers.
    PLoS One. 2021;16:e0250017.
    PubMed         Abstract available

  137. YING F, O'Clery N
    Modelling COVID-19 transmission in supermarkets using an agent-based model.
    PLoS One. 2021;16:e0249821.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  138. MENA EL, Donahue CJ, Vaites LP, Li J, et al
    ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  139. ENGZELL P, Frey A, Verhagen MD
    Learning loss due to school closures during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  140. GRANGE ZL, Goldstein T, Johnson CK, Anthony S, et al
    Ranking the risk of animal-to-human spillover for newly discovered viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    Opinion: We need to improve the welfare of life science trainees.
    Proc Natl Acad Sci U S A. 2021;118.

  142. TKACHENKO AV, Maslov S, Elbanna A, Wong GN, et al
    Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  143. PRESTON SH, Vierboom YC
    Excess mortality in the United States in the 21st century.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  144. KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
    NIH funding for vaccine readiness before the COVID-19 pandemic.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
    PubMed         Abstract available


  145. UPRETY T, Sreenivasan CC, Bhattarai S, Wang D, et al
    Isolation and development of bovine primary respiratory cells as model to study influenza D virus infection.
    Virology. 2021;559:89-99.
    PubMed         Abstract available

  146. NAYAK K, Gottimukkala K, Kumar S, Reddy ES, et al
    Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.
    Virology. 2021;558:13-21.
    PubMed         Abstract available

  147. XIE L, Yi K, Li Y
    SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
    Virology. 2021;558:22-27.
    PubMed         Abstract available

  148. WATERS K, Wan HJ, Han L, Xue J, et al
    Variations outside the conserved motifs of PB1 catalytic active site may affect replication efficiency of the RNP complex of influenza A virus.
    Virology. 2021;559:145-155.
    PubMed         Abstract available

  149. TERRY JS, Anderson LB, Scherman MS, McAlister CE, et al
    Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
    Virology. 2021;558:28-37.
    PubMed         Abstract available

  150. NOLAN KE, Baer LA, Karekar P, Nelson AM, et al
    Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus.
    Virology. 2021;559:111-119.
    PubMed         Abstract available

  151. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
    Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Virology. 2021;558:1-12.
    PubMed         Abstract available

    Virus Res

  152. LEE S, Won D, Kim CK, Ahn J, et al
    Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
    Virus Res. 2021;297:198398.
    PubMed         Abstract available

  153. HASAN MM, Das R, Rasheduzzaman M, Hussain MH, et al
    Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Virus Res. 2021;297:198390.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.